Literature DB >> 26545495

Increased miR-374b promotes cell proliferation and the production of aberrant glycosylated IgA1 in B cells of IgA nephropathy.

Shuai Hu1, Hao Bao2, Xiaodong Xu1, Xianguang Zhou1, Weisong Qin1, Caihong Zeng1, Zhihong Liu3.   

Abstract

The number of B cells is increased and the O-glycans of IgA1 are incompletely galactosylated in IgA nephropathy (IgAN). Here we report that expression of phosphatase and tensin homolog (PTEN) and Cosmc is decreased in B cells, and correlates with B cell number and the aberrant glycosylation of IgA1 in IgAN. Patients with IgAN exhibit higher miR-374b in B cells compared to controls. We show that miR-374b targets PTEN and Cosmc by luciferase assays and western blot analysis. Inhibition of miR-374b increased PTEN and Cosmc expression, and prevented cell proliferation and aberrant glycosylation of IgA1, thus representing a new therapeutic approach for IgAN.
Copyright © 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  B cell; IgA nephropathy; MiR-374b

Mesh:

Substances:

Year:  2015        PMID: 26545495     DOI: 10.1016/j.febslet.2015.10.033

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  20 in total

Review 1.  Cytokines and Production of Aberrantly O-Glycosylated IgA1, the Main Autoantigen in IgA Nephropathy.

Authors:  Taylor Person; R Glenn King; Dana V Rizk; Jan Novak; Todd J Green; Colin Reily
Journal:  J Interferon Cytokine Res       Date:  2022-07-06       Impact factor: 3.657

Review 2.  Recent findings on the role of microRNAs in genetic kidney diseases.

Authors:  Hassan Askari; Ehsan Raeis-Abdollahi; Mohammad Foad Abazari; Hassan Akrami; Sina Vakili; Amir Savardashtaki; Amir Tajbakhsh; Nima Sanadgol; Asaad Azarnezhad; Leila Rahmati; Payman Raise Abdullahi; Shohreh Zare Karizi; Ali Reza Safarpour
Journal:  Mol Biol Rep       Date:  2022-06-18       Impact factor: 2.742

3.  The long noncoding RNA LOC105374325 causes podocyte injury in individuals with focal segmental glomerulosclerosis.

Authors:  Shuai Hu; Runhong Han; Jingsong Shi; Xiaodong Zhu; Weisong Qin; Caihong Zeng; Hao Bao; Zhihong Liu
Journal:  J Biol Chem       Date:  2018-11-02       Impact factor: 5.157

Review 4.  The Role of NcRNAs to Regulate Immune Checkpoints in Cancer.

Authors:  Yicun Jiang; Leilei Zhao; Yiwen Wu; Sijun Deng; Pu Cao; Xiaoyong Lei; Xiaoyan Yang
Journal:  Front Immunol       Date:  2022-04-06       Impact factor: 8.786

5.  MicroRNAs: a new avenue to understand, investigate and treat immunoglobulin A nephropathy?

Authors:  Haresh Selvaskandan; Izabella Pawluczyk; Jonathan Barratt
Journal:  Clin Kidney J       Date:  2017-09-23

6.  Small RNA deep sequencing reveals novel miRNAs in peripheral blood mononuclear cells from patients with IgA nephropathy.

Authors:  Ziyan Wang; Yu Liao; Lixin Wang; Yanzhao Lin; Ziyi Ye; Xufang Zeng; Xiaorou Liu; Fangning Wei; Nizhi Yang
Journal:  Mol Med Rep       Date:  2020-08-03       Impact factor: 2.952

Review 7.  The Non-Coding RNA Landscape in IgA Nephropathy-Where Are We in 2021?

Authors:  Izabella Z A Pawluczyk; Haresh Selvaskandan; Jonathan Barratt
Journal:  J Clin Med       Date:  2021-05-28       Impact factor: 4.241

8.  MicroRNA-374b inhibits liver cancer progression via down regulating programmed cell death-1 expression on cytokine-induced killer cells.

Authors:  Fen Huang; Bo Wang; Jiangzheng Zeng; Shenggang Sang; Junhua Lei; Yanda Lu
Journal:  Oncol Lett       Date:  2018-02-05       Impact factor: 2.967

9.  MiR-374b Promotes Proliferation and Inhibits Apoptosis of Human GIST Cells by Inhibiting PTEN through Activation of the PI3K/Akt Pathway.

Authors:  Zi-Wen Long; Jiang-Hong Wu; Ya-Nong Wang; Ye Zhou
Journal:  Mol Cells       Date:  2018-06-14       Impact factor: 5.034

10.  Hyperglycemia Affects miRNAs Expression Pattern during Adipogenesis of Human Visceral Adipocytes-Is Memorization Involved?

Authors:  Justyna Strycharz; Ewa Świderska; Adam Wróblewski; Marta Podolska; Piotr Czarny; Janusz Szemraj; Aneta Balcerczyk; Józef Drzewoski; Jacek Kasznicki; Agnieszka Śliwińska
Journal:  Nutrients       Date:  2018-11-15       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.